United Biomedical Inc. became the second Taiwanese COVID-19 vaccine developer to receive Food and Drug Administration (FDA) approval to begin a phase 2 clinical trial, the regulator said in statement released on Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Cross-Strait
17 PLA aircraft cross Taiwan Strait median line or extension: Ministry
04/20/2024 12:57 PM - Business
Tech expert and witness to semiconductor boom, urges Taiwan to think big
04/20/2024 12:50 PM - Society
Taiwan to soon welcome its first indigenous dog as a police canine
04/20/2024 12:43 PM - Politics
G7 reiterates importance of cross-strait peace and stability
04/20/2024 12:04 PM - Society
Taiwan headline news
04/20/2024 11:23 AM